DE60116530D1 - Prozess zur herstellung einer oralen arzneiform - Google Patents

Prozess zur herstellung einer oralen arzneiform

Info

Publication number
DE60116530D1
DE60116530D1 DE60116530T DE60116530T DE60116530D1 DE 60116530 D1 DE60116530 D1 DE 60116530D1 DE 60116530 T DE60116530 T DE 60116530T DE 60116530 T DE60116530 T DE 60116530T DE 60116530 D1 DE60116530 D1 DE 60116530D1
Authority
DE
Germany
Prior art keywords
core
manufacture
oral medicine
outer coating
exterior
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60116530T
Other languages
English (en)
Other versions
DE60116530T2 (de
Inventor
C O Glaxosmithkline Martini
C O Glaxosmithkline Smith
C O Glaxosmithkline Li
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Ltd
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd, SmithKline Beecham Corp filed Critical SmithKline Beecham Ltd
Application granted granted Critical
Publication of DE60116530D1 publication Critical patent/DE60116530D1/de
Publication of DE60116530T2 publication Critical patent/DE60116530T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
    • B23B—TURNING; BORING
    • B23B37/00—Boring by making use of ultrasonic energy
DE60116530T 2000-11-08 2001-11-02 Prozess zur herstellung einer oralen arzneiform Expired - Lifetime DE60116530T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0027471.2A GB0027471D0 (en) 2000-11-08 2000-11-08 Processes
GB0027471 2000-11-08
PCT/EP2001/012729 WO2002038131A2 (en) 2000-11-08 2001-11-02 Process

Publications (2)

Publication Number Publication Date
DE60116530D1 true DE60116530D1 (de) 2006-03-30
DE60116530T2 DE60116530T2 (de) 2006-08-10

Family

ID=9902924

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60116530T Expired - Lifetime DE60116530T2 (de) 2000-11-08 2001-11-02 Prozess zur herstellung einer oralen arzneiform
DE60138428T Expired - Lifetime DE60138428D1 (de) 2000-11-08 2001-11-02 Oralen Arzneiform mit Oeffnungen in der äusseren Hülle

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE60138428T Expired - Lifetime DE60138428D1 (de) 2000-11-08 2001-11-02 Oralen Arzneiform mit Oeffnungen in der äusseren Hülle

Country Status (9)

Country Link
US (2) US7923027B2 (de)
EP (2) EP1655024B1 (de)
JP (1) JP4290981B2 (de)
AT (2) ATE428407T1 (de)
AU (1) AU2002218280A1 (de)
DE (2) DE60116530T2 (de)
ES (2) ES2256329T3 (de)
GB (1) GB0027471D0 (de)
WO (1) WO2002038131A2 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040081697A1 (en) * 1998-11-12 2004-04-29 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
US20030153607A1 (en) * 1998-11-12 2003-08-14 Smithkline Beecham P.L.C. Novel composition and use
MXPA04002979A (es) * 2001-09-28 2005-06-20 Johnson & Johnson Formas de dosificacion de liberacion modificada.
US20040253312A1 (en) * 2001-09-28 2004-12-16 Sowden Harry S. Immediate release dosage form comprising shell having openings therein
GB0203296D0 (en) 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
PE20030800A1 (es) * 2002-02-12 2003-10-31 Glaxo Group Ltd Forma de dosificacion oral de liberacion controlada
US8637512B2 (en) 2002-07-29 2014-01-28 Glaxo Group Limited Formulations and method of treatment
EP1545452A1 (de) * 2002-09-28 2005-06-29 McNEIL-PPC, INC. Dosierungsformen mit modifizierter freisetzung
GB0318824D0 (en) * 2003-08-11 2003-09-10 Glaxo Group Ltd Novel composition
US20050169994A1 (en) * 2003-11-25 2005-08-04 Burke Matthew D. Carvedilol free base, salts, anhydrous forms or solvates thereof, corresponding pharmaceutical compositions, controlled release formulations, and treatment or delivery methods
US8067029B2 (en) * 2004-01-13 2011-11-29 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US7879354B2 (en) * 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US7404708B2 (en) * 2004-12-07 2008-07-29 Mcneil-Ppc, Inc. System and process for providing at least one opening in dosage forms
BRPI0520830A2 (pt) * 2005-12-30 2009-05-19 Accu Break Technologies Inc forma de dosagem farmacêutica sólida, método de subdividir uma forma de dosagem farmacêutica sólida, método de administração de uma parte de uma subunidade ativa de uma forma de dosagem farmacêutica sólida, método de administração de um ingrediente farmacêutico ativo que está presente dentro de uma subunidade ativa de uma forma de dosagem farmacêutica sólida e método de produção de uma forma de dosagem farmacêutica sólida
US8273105B2 (en) * 2008-02-20 2012-09-25 Tyco Healthcare Group Lp Compound barb medical device and method
AU2008357475B2 (en) 2008-06-04 2012-11-01 Colgate-Palmolive Company Oral care implement with cavitation system
JP2011528666A (ja) * 2008-07-18 2011-11-24 バレアント プハルマセウトイカルス インターナショナル 放出調節製剤及びその使用方法
US20100323015A1 (en) * 2008-07-18 2010-12-23 Biljana Nadjsombati Modified release formulation and methods of use
US20100323016A1 (en) * 2008-07-18 2010-12-23 Biljana Nadjsombati Modified release formulation and methods of use
EP3968966A1 (de) 2019-05-17 2022-03-23 GlaxoSmithKline Intellectual Property Development Ltd Matrixzusammensetzung mit (s)-5-benzyl-n-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[ b][1,4] oxazepin-3-yl)-4h-1,2,4-triazol-3-carboxamid

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1575050A1 (de) * 1966-01-12 1972-04-13 Misto Gen Equipment Co Ultraschall-Nebelerzeugungsgeraet
US4447235A (en) * 1981-05-07 1984-05-08 John M. Clarke Thoracentesis device
US4693886A (en) * 1985-04-22 1987-09-15 Alza Corporation Osmotic device with inert core
EP0303769A3 (de) * 1987-08-18 1989-10-25 Balzers Aktiengesellschaft Vorrichtung zur Übertragung von Drehbewegungen durch die Wand einer Vakuumkammer
GB8820353D0 (en) * 1988-08-26 1988-09-28 Staniforth J N Controlled release tablet
JPH02124251A (ja) 1988-10-28 1990-05-11 Tanaka Kikinzoku Kogyo Kk 微細穴加工方法
US5123903A (en) * 1989-08-10 1992-06-23 Medical Products Development, Inc. Disposable aspiration sleeve for ultrasonic lipectomy
US5317932A (en) * 1992-02-28 1994-06-07 The Dow Chemical Company Sample probe
US5300046A (en) * 1992-03-30 1994-04-05 Symbiosis Corporation Thoracentesis sheath catheter assembly
US5674235A (en) * 1995-05-10 1997-10-07 Ultralase Technologies International Ultrasonic surgical cutting instrument
JPH1024491A (ja) 1996-07-11 1998-01-27 Seidensha Denshi Kogyo Kk 超音波加工装置
US6783662B2 (en) * 1999-03-18 2004-08-31 Exxonmobil Research And Engineering Company Cavitation enhanced liquid atomization
CA2378829A1 (en) * 1999-07-20 2001-01-25 Merck & Co., Inc. Sustained release drug dispersion delivery device
CA2388159A1 (en) * 1999-10-29 2001-05-10 Merck & Co., Inc. Osmotic controlled release drug delivery device
US7708504B2 (en) * 2005-08-29 2010-05-04 Savannah River Nuclear Solutions, Llc Pneumatic conveyance apparatus and process

Also Published As

Publication number Publication date
DE60138428D1 (de) 2009-05-28
EP1655024A1 (de) 2006-05-10
ATE314839T1 (de) 2006-02-15
DE60116530T2 (de) 2006-08-10
AU2002218280A1 (en) 2002-05-21
US20040062806A1 (en) 2004-04-01
JP4290981B2 (ja) 2009-07-08
WO2002038131A2 (en) 2002-05-16
ES2256329T3 (es) 2006-07-16
ATE428407T1 (de) 2009-05-15
ES2323879T3 (es) 2009-07-27
EP1333813A2 (de) 2003-08-13
EP1655024B1 (de) 2009-04-15
US20110131754A1 (en) 2011-06-09
US8765065B2 (en) 2014-07-01
GB0027471D0 (en) 2000-12-27
US7923027B2 (en) 2011-04-12
JP2004512903A (ja) 2004-04-30
WO2002038131A3 (en) 2002-09-12
EP1333813B1 (de) 2006-01-04

Similar Documents

Publication Publication Date Title
DE60116530D1 (de) Prozess zur herstellung einer oralen arzneiform
CA2433032A1 (en) Sustained release drug delivery devices with coated drug cores
DE60223269D1 (de) Darreichungsformen zur modifizierten freisetzung
NO20035655L (no) Fremgangsmate for fremstilling av tabletter
ES2036457A1 (es) Forma de dosificacion farmaceutica solida oral de liberacion programada y procedimiento de preparacion.
CA2413084A1 (en) Pacifier
DE60045121D1 (de) Beschichtungsflüssigkeit zur Herstellung organischer elektrolumineszenter Vorrichtungen
WO2002072033A3 (en) Chronotherapeutic dosage forms containing glucocorticosteroid
ATE380518T1 (de) Einstückiges dentalimplantat und verfahren zu dessen herstellung
AU2001261780A1 (en) Hydrophilic coating including dlc on substrate
CY1111825T1 (el) Φαρμακευτικες συνθεσεις οι οποιες περιλαμβανουν ενα οπιουχο ανταγωνιστη
DE60029589D1 (de) Verfahren zur herstellung von azithromycin
AU2715701A (en) Wire, tube or catheter with hydrophilic coating
WO2005105038A3 (en) A system and a method for producing layered oral dosage forms
NO20033305D0 (no) Nytt filmbelegg
DE60137386D1 (de) Phosphor-Dünnfilm, Verfahren zur Herstellung und EL-Folie
DE60042972D1 (de) Trimetazidine enthaltendes Arzneimittel mit verzögerter Wirkstoffabgabe und Verfahren zur Herstellung
DK1413259T3 (da) Dental formdel, især kunstig tand
EP1250937A3 (de) Kontrollierte Auflösung von Wirkstoffen
DE60321801D1 (de) Sphäroide, deren herstellungsverfahren und sphäroidenhaltige arzneimittel
DE60033207D1 (de) Werkzeug zur herstellung von nockenwellen durch einwalzen
ATE307214T1 (de) Verfahren zur herstellung einer aus pflanzen stammenden, antibakteriellen substanz
DE50114938D1 (de) Maskenerstellung zur Herstellung einer Druckform
DE50207427D1 (de) Vorrichtung zur Herstellung palettierfähiger Lagen
DE59510932D1 (de) Verfahren zur Herstellung von Vorrichtungen zur kontrollierten Freisetzung von Wirkstoffen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition